Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Byrne

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Oncologist|October 9, 2015
Hope Is PalliativeJulie Byrne, Michael Byrne
The Journal of IMA|April 24, 2013
Compassionate careStephen G Post, Julie Byrne
BMJ Open Quality|May 3, 2018
Reducing the rate of post-surgical urinary tract infections in orthopedic patientsAmit Thakker, Natasha Briggs, Azusa Maeda, et al.
Mayo Clinic Proceedings|June 6, 2008
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trialsEdith A Perez, Maria Koehler, Julie Byrne, et al.
Pharmacogenomics|August 13, 2015
Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphismsLaura R Parham, Linda P Briley, Karen S King, et al.
Work (Reading, Mass.)|September 19, 2017
Parental awareness of schoolbag carriage: A comparative study of Irish and United States parentsSara Dockrell, Karen Jacobs, Julie Byrne, et al.
Breast Cancer Research and Treatment|January 22, 2008
Pooled analysis of diarrhea events in patients with cancer treated with lapatinibJohn P Crown, Harold A Burris, Fran Boyle, et al.
Blood Cancer Journal|October 24, 2020
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 studyPaul G Richardson, Hans C Lee, Al-Ola Abdallah, et al.
Ophthalmology and Therapy|July 27, 2020
Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 StudyAsim V Farooq, Simona Degli Esposti, Rakesh Popat, et al.
Ophthalmology and Therapy|September 13, 2020
Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 StudyAsim V Farooq, Simona Degli Esposti, Rakesh Popat, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Oncologist|October 9, 2015
Hope Is PalliativeJulie Byrne, Michael Byrne
The Journal of IMA|April 24, 2013
Compassionate careStephen G Post, Julie Byrne
BMJ Open Quality|May 3, 2018
Reducing the rate of post-surgical urinary tract infections in orthopedic patientsAmit Thakker, Natasha Briggs, Azusa Maeda, et al.
Mayo Clinic Proceedings|June 6, 2008
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trialsEdith A Perez, Maria Koehler, Julie Byrne, et al.
Pharmacogenomics|August 13, 2015
Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphismsLaura R Parham, Linda P Briley, Karen S King, et al.
Work (Reading, Mass.)|September 19, 2017
Parental awareness of schoolbag carriage: A comparative study of Irish and United States parentsSara Dockrell, Karen Jacobs, Julie Byrne, et al.
Breast Cancer Research and Treatment|January 22, 2008
Pooled analysis of diarrhea events in patients with cancer treated with lapatinibJohn P Crown, Harold A Burris, Fran Boyle, et al.
Blood Cancer Journal|October 24, 2020
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 studyPaul G Richardson, Hans C Lee, Al-Ola Abdallah, et al.
Ophthalmology and Therapy|July 27, 2020
Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 StudyAsim V Farooq, Simona Degli Esposti, Rakesh Popat, et al.
Ophthalmology and Therapy|September 13, 2020
Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 StudyAsim V Farooq, Simona Degli Esposti, Rakesh Popat, et al.
Pageof 2